Orgenesis

Orgenesis

Biotechnology, Goldenrod Ln, Germantown, , 20876, Maryland, 20271, United States, 51-200 Employees

orgenesis.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 48********

Who is ORGENESIS

Orgenesis is a global biotech company that has been committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2012. Orgenesis established the POCare Netwo...

Read More

map
  • 20271 Goldenrod Ln, Germantown, Maryland, 20876, United States Headquarters: 20271 Goldenrod Ln, Germantown, Maryland, 20876, United States
  • 2012 Date Founded: 2012
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 32 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ORGENESIS

Orgenesis Org Chart and Mapping

Employees

Tal Eyal

Manufacturing Supervisor

Greg Roumeliotis

Vice President of Global Business Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Orgenesis

Answer: Orgenesis's headquarters are located at Goldenrod Ln, Germantown, , 20876, Maryland, 20271, United States

Answer: Orgenesis's phone number is 48********

Answer: Orgenesis's official website is https://orgenesis.com

Answer: Orgenesis's revenue is $10 Million to $25 Million

Answer: Orgenesis's SIC: 2834

Answer: Orgenesis's NAICS: 32

Answer: Orgenesis has 51-200 employees

Answer: Orgenesis is in Biotechnology

Answer: Orgenesis contact info: Phone number: 48******** Website: https://orgenesis.com

Answer: Orgenesis is a global biotech company that has been committed to unlocking the potential of decentralized cell and gene therapies (CGTs) since 2012. Orgenesis established the POCare Network in 2020 to bring academia, hospitals, and Industry together to make these innovations more affordable and accessible to patients. In 2022, the POCare Services business unit responsible for developing and managing the decentralized POCare Centers and proprietary OMPULs was formed. Orgenesis will continue to focus on advancing to market through various partnerships its CGTs to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access